An Overview About the Role of Adaptive Immunity in Keeping SARS-CoV-2 Reinfections at Bay

被引:2
作者
Ahsan, Haseeb [1 ,2 ]
Sonn, Jong Kyung [1 ]
Lee, Young Sup [1 ]
Ul Islam, Salman [1 ]
Khalil, Saifullah Khan [2 ]
机构
[1] Kyungpook Natl Univ, Coll Nat Sci, Sch Life Sci, 80 Daehakro, Daegu 41566, South Korea
[2] Univ Peshawar, Fac Life & Environm Sci, Dept Pharm, Peshawar, Pakistan
基金
新加坡国家研究基金会;
关键词
reinfection; vaccine; adaptive immunity; SARS-CoV-2; NEUTRALIZING ANTIBODIES; INFECTION ENHANCEMENT; COVID-19; INFECTION; PATHOGENESIS; MACROPHAGES; CHALLENGES;
D O I
10.1089/vim.2021.0017
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Coronavirus disease 2019 (COVID-19) is a worldwide emergency that has affected millions of populations in developed and underdeveloped countries. To our surprise, many people have been tested positive twice. Few cases of true reinfections involved genetic alterations in the virus. Appearance of multiple positive tests may be due to human errors or remnant genetic material, but genetic modification in virus represents very serious issue of controlling this pandemic. It is the need of the day that all the gaps and deficiencies, represented by variable response of adaptive immune system toward this infection, be filled and rectified. We have discussed reinfections with variable outcomes along with the possible reasons for variable response. Phenomena such as T cell memory, absence of cross-reactive immunity, T cell exhaustion, drawbacks pertaining to neutralizing antibodies, and immune enhancement are crucial areas by which adaptive immune response can weaken considerably. Earlier and stronger herd immunity is also at the mercy of strong adaptive immune system to avoid future pandemics by the same microorganism. Likewise, consequences of this phenomenon should also be considered during vaccine development as resources worth billions are being used and staked. Many countries have entered the second/third waves of COVID-19. Therefore, we need to come up with ways toward uniform strengthening of adaptive immune response to fight off this pandemic. Also, to develop and maintain constant resistance to severe acute respiratory syndrome coronavirus (SARS-CoV-2), the mentioned weakened links in the chain of adaptive immunity may be explored to keep viral invasion and physiological damage to minimum.
引用
收藏
页码:588 / 596
页数:9
相关论文
共 72 条
[1]   Why the immune system fails to mount an adaptive immune response to a COVID-19 infection [J].
Ahmadpoor, Pedram ;
Rostaing, Lionel .
TRANSPLANT INTERNATIONAL, 2020, 33 (07) :824-825
[2]  
Alberts B., 2002, MOL BIOL CELL
[3]   Immune Memory in Mild COVID-19 Patients and Unexposed Donors Reveals Persistent T Cell Responses After SARS-CoV-2 Infection [J].
Ansari, Asgar ;
Arya, Rakesh ;
Sachan, Shilpa ;
Jha, Someshwar Nath ;
Kalia, Anurag ;
Lall, Anupam ;
Sette, Alessandro ;
Grifoni, Alba ;
Weiskopf, Daniela ;
Coshic, Poonam ;
Sharma, Ashok ;
Gupta, Nimesh .
FRONTIERS IN IMMUNOLOGY, 2021, 12
[4]   CRISPR-Cas14 is now part of the artillery for gene editing and molecular diagnostic [J].
Aquino-Jarquin, Guillermo .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2019, 18 :428-431
[5]   A perspective on potential antibody-dependent enhancement of SARS-CoV-2 [J].
Arvin, Ann M. ;
Fink, Katja ;
Schmid, Michael A. ;
Cathcart, Andrea ;
Spreafico, Roberto ;
Havenar-Daughton, Colin ;
Lanzavecchia, Antonio ;
Corti, Davide ;
Virgin, Herbert W. .
NATURE, 2020, 584 (7821) :353-363
[6]  
Bao L., 2020, START REINFECTION CO, DOI 10.1101/2020.03.13.990226v1.full?fbclid=IwAR0bNmFCEwxzjiyMnK8ZPq7CUauOkJJeQ-ye6HQdFPcto4TVl9Vov7sPVzA/
[7]   Autoantibodies against type I IFNs in patients with life-threatening COVID-19 [J].
Bastard, Paul ;
Rosen, Lindsey B. ;
Zhang, Qian ;
Michailidis, Eleftherios ;
Hoffmann, Hans-Heinrich ;
Zhang, Yu ;
Dorgham, Karim ;
Philippot, Quentin ;
Rosain, Jeremie ;
Beziat, Vivien ;
Manry, Jeremy ;
Shaw, Elana ;
Haljasmagi, Liis ;
Peterson, Part ;
Lorenzo, Lazaro ;
Bizien, Lucy ;
Trouillet-Assant, Sophie ;
Dobbs, Kerry ;
de Jesus, Adriana Almeida ;
Belot, Alexandre ;
Kallaste, Anne ;
Catherinot, Emilie ;
Tandjaoui-Lambiotte, Yacine ;
Le Pen, Jeremie ;
Kerner, Gaspard ;
Bigio, Benedetta ;
Seeleuthner, Yoann ;
Yang, Rui ;
Bolze, Alexandre ;
Spaan, Andras N. ;
Delmonte, Ottavia M. ;
Abers, Michael S. ;
Aiuti, Alessandro ;
Casari, Giorgio ;
Lampasona, Vito ;
Piemonti, Lorenzo ;
Ciceri, Fabio ;
Bilguvar, Kaya ;
Lifton, Richard P. ;
Vasse, Marc ;
Smadja, David M. ;
Migaud, Melanie ;
Hadjadj, Jerome ;
Terrier, Benjamin ;
Duffy, Darragh ;
Quintana-Murci, Lluis ;
van de Beek, Diederik ;
Roussel, Lucie ;
Vinh, Donald C. ;
Tangye, Stuart G. .
SCIENCE, 2020, 370 (6515) :423-+
[8]   Persistent cellular immunity to SARS-CoV-2 infection [J].
Breton, Gaelle ;
Mendoza, Pilar ;
Hagglof, Thomas ;
Oliveira, Thiago Y. ;
Schaefer-Babajew, Dennis ;
Gaebler, Christian ;
Turroja, Martina ;
Hurley, Arlene ;
Caskey, Marina ;
Nussenzweig, Michel C. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2021, 218 (04)
[9]   HIV vaccine design and the neutralizing antibody problem [J].
Burton, DR ;
Desrosiers, RC ;
Doms, RW ;
Koff, WC ;
Kwong, PD ;
Moore, JP ;
Nabel, GJ ;
Sodroski, J ;
Wilson, IA ;
Wyatt, RT .
NATURE IMMUNOLOGY, 2004, 5 (03) :233-236
[10]  
Centers for Disease Control and Prevention, REINF COVID 19